600479 千金药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.91413.91113.85313.67713.370
总资产报酬率 ROA (%)0.9816.8826.9587.2887.389
投入资产回报率 ROIC (%)1.53310.71410.75810.91210.296

边际利润分析
销售毛利率 (%)45.74046.11743.12744.53344.009
营业利润率 (%)7.12312.16111.03411.90611.695
息税前利润/营业总收入 (%)7.01710.92510.99011.66310.949
净利润/营业总收入 (%)6.09610.3999.61510.2289.931

收益指标分析
经营活动净收益/利润总额(%)111.32996.05892.33183.48187.740
价值变动净收益/利润总额(%)-2.4253.4474.4086.0945.692
营业外收支净额/利润总额(%)0.336-0.3300.351-0.6480.096

偿债能力分析
流动比率 (X)2.3032.2792.0702.3752.315
速动比率 (X)1.9481.9331.7171.9291.954
资产负债率 (%)35.08535.28339.21733.50334.685
带息债务/全部投入资本 (%)15.70117.37921.60814.713--
股东权益/带息债务 (%)515.131456.082345.886549.891418.089
股东权益/负债合计 (%)146.649144.817121.975158.081154.546
利息保障倍数 (X)-53.735-9.135-132.889-69.843-14.467

营运能力分析
应收账款周转天数 (天)28.53723.97121.42222.8920.000
存货周转天数 (天)89.90299.65390.14592.5200.000